Thiabendazole: a new immunopotentiator effective in therapy of murine fibrosarcoma.
D000818:Animals; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D009365:Neoplasm Regression, Spontaneous; D013827:Thiabendazole / Q000276:immunology / Q000627:therapeutic use*
D004317:Doxorubicin; D013827:Thiabendazole